Literature DB >> 18178360

Optimization and validation of a dissolution test for selegiline hydrochloride tablets by a novel rapid HPLC assay using a monolithic stationary phase.

Paraskevas D Tzanavaras1, Demetrius G Themelis, Anastasia Zotou, John Stratis, Bo Karlberg.   

Abstract

The present study reports the optimization and validation of a dissolution test for selegiline.HCl tablets using a new high-performance liquid chromatographic (HPLC) method. Rapid separation of the analyte from sample matrix was achieved in less than 60s using a Cromolith RP-18e monolithic column using UV detection at 220 nm. Thorough validation of the assay based on pre-defined criteria included linearity, LOD/LOQ, accuracy, precision, selectivity and ruggedness. The dissolution test was optimized in terms of dissolution medium, basket (type I)/paddle (type II) agitation and rotation speed. Its ruggedness was also validated. The presented analytical and dissolution procedures are currently being applied in the quality and stability control of Cosmopril tablets (5mg/tablet selegiline.HCl, Cosmopharm Ltd., Korinthos, Greece).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18178360     DOI: 10.1016/j.jpba.2007.11.039

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products.

Authors:  J W Collier; R B Shah; A R Bryant; M J Habib; M A Khan; P J Faustino
Journal:  J Pharm Biomed Anal       Date:  2010-10-13       Impact factor: 3.935

2.  Interaction of selegiline-loaded PLGA-b-PEG nanoparticles with beta-amyloid fibrils.

Authors:  Ipek Baysal; Samiye Yabanoglu-Ciftci; Yeliz Tunc-Sarisozen; Kezban Ulubayram; Gulberk Ucar
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

3.  Development and validation of new discriminative dissolution method for carvedilol tablets.

Authors:  V Raju; K V R Murthy
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.